Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
about
Type I interferons for induction of remission in ulcerative colitisType I interferons for induction of remission in ulcerative colitisActivation of epithelial CD98 glycoprotein perpetuates colonic inflammationReview article: Infliximab therapy for inflammatory bowel disease--seven years onChronic inflammation up-regulates P-gp in peripheral mononuclear blood cells via the STAT3/Nf-κb pathway in 2,4,6-trinitrobenzene sulfonic acid-induced colitis miceInflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice.Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.Validated gene expression biomarker analysis for biopsy-based clinical trials in ulcerative colitis.Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells.Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitisVitamin D deficiency in patients with intestinal malabsorption syndromes--think in and outside the gut.Infliximab therapy for moderately severe Crohn's disease and ulcerative colitis: a retrospective comparison over 6 years.Crotoxin from Crotalus durissus terrificus is able to down-modulate the acute intestinal inflammation in mice.C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up studyIFNγ Induces DNA Methylation-Silenced GPR109A Expression via pSTAT1/p300 and H3K18 Acetylation in Colon Cancer.Mechanisms of acupuncture and moxibustion in regulation of epithelial cell apoptosis in rat ulcerative colitis.Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitisInterfering with interferons in inflammatory bowel disease.Bioluminescence imaging for IL-1β expression in experimental colitis.Intestinal epithelial CD98: an oligomeric and multifunctional protein.Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis.N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot studyEffect of Helicobacter pylori and its virulence factors on portal hypertensive gastropathy and interleukin (IL)-8, IL-10, and tumor necrosis factor-alpha levels.Antitumor necrosis factor treatment for pediatric inflammatory bowel disease.Neutrophil differentiated HL-60 cells model Mac-1 (CD11b/CD18)-independent neutrophil transepithelial migration.Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study.Therapeutic effect of a hydroxynaphthoquinone fraction on dextran sulfate sodium-induced ulcerative colitis.Constitutive expression of MMP9 in intestinal epithelium worsens murine acute colitis and is associated with increased levels of proinflammatory cytokine Kc.Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis.Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab.Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis.The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.Predictors of early response to infliximab in patients with ulcerative colitis.Predictive value of mucosal TNF-alpha transcripts in steroid-refractory Crohn's disease patients receiving intensive immunosuppressive therapy.Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases.
P2860
Q24187202-2BCC07CD-4826-43A6-B07F-51329AFF7322Q24241993-96F6D0A9-7C03-460C-99D5-747B1B1A527EQ28249215-5F75A612-48DD-404E-B647-78AF7875D5C9Q28294134-F6DD7795-0D9B-4589-BC72-7880ABDCCB2BQ28608251-B38593C8-E26C-4CF0-913E-1E6715B0CF59Q33762244-E767E6D0-FDA4-4FEF-902E-F9D807D33151Q33886458-03A2F71A-06F2-472A-9051-4EDD76D2BA1EQ34084800-64EB3B95-0F12-4D06-B2A0-9185654FFAE7Q34269623-BD131AE6-1753-4B58-B4BA-C4920D187A06Q34437894-C8EB7886-C7A2-45E4-8EE7-E0BA9A74D8B3Q34491388-BB87DC7E-3F28-48F0-B4BF-80406DEE77BFQ35026410-81AF689D-BD65-4F83-8558-084DAD02C6A1Q35597581-BC741922-A0D8-4973-B263-E23461EEBA05Q35745374-02756E48-52EF-4EB7-8271-98DBBDE8BBF9Q35815888-D98489B5-B2AC-4550-BD26-34FB09127FE1Q36474134-18F31FAA-3977-4F0C-B8BE-F7ABF1E2E0FEQ36474506-C6D22FCB-0368-48E9-9334-C415F42566C5Q36540026-968646F4-B965-4CD3-9C3E-411DF98962C3Q36794223-89F6F20F-A1EB-4003-B7B8-3E475040B842Q37014916-BF364FBE-9DF8-4F13-9013-BDA01A87421CQ37098695-24FDEC90-987E-48FC-A804-FD4FF16A74A1Q37261921-564A7B47-A769-4A43-9AD4-9AA77927603DQ37703505-E97C9C7F-F53A-4053-8BFB-8462005CEA1DQ37936394-F32D6D24-23FD-4CC9-A5E7-C57E719CA7C2Q40437068-7FD98ECD-B330-4163-A186-500E157E6E46Q40525397-3DC295F6-61CD-4181-80E1-1F9FEF191DB2Q42111707-94069597-4194-49D6-9753-90190B342D17Q42435344-6E737A7F-3A57-4EA4-A755-D0F827260276Q42704574-FCE68CCD-0560-43CA-B87E-0132A3F8B29BQ42775426-60C6A104-8F98-46F2-88C0-0FF5ACCB662CQ43700132-92801691-EA85-4683-A6C5-DE4BDE03AA0DQ44539365-73FE7C39-250D-471E-B26C-92525DF1131CQ46303987-54B8BABA-C4EE-4E9D-9815-65F0AB3019C4Q51771485-73A755A0-BFD5-47D1-B697-CB0D15C2A50CQ54563954-9DBE6BDA-A714-4AD7-8A3D-F3F0885EC2C3Q55409256-623D4FA1-9CB4-4E35-9E7A-E5F4BF657090
P2860
Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Cytokine profile in colonic mu ...... sponse to granulocytapheresis.
@en
Cytokine profile in colonic mu ...... sponse to granulocytapheresis.
@nl
type
label
Cytokine profile in colonic mu ...... sponse to granulocytapheresis.
@en
Cytokine profile in colonic mu ...... sponse to granulocytapheresis.
@nl
prefLabel
Cytokine profile in colonic mu ...... sponse to granulocytapheresis.
@en
Cytokine profile in colonic mu ...... sponse to granulocytapheresis.
@nl
P2093
P2860
P1476
Cytokine profile in colonic mu ...... sponse to granulocytapheresis.
@en
P2093
Bun-ei Iizuka
Mitsutoshi Iimura
Naoaki Hayashi
Tetsuo Nakamura
Yuriko Tsukada
P2860
P304
P356
10.1111/J.1572-0241.2002.07029.X
P407
P577
2002-11-01T00:00:00Z